» Articles » PMID: 23681823

Variability of Histamine Pharmacodynamic Response in Children with Allergic Rhinitis

Overview
Publisher Wiley
Specialty Pharmacology
Date 2013 May 18
PMID 23681823
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Histamine iontophoresis with laser Doppler monitoring (HILD) is a robust and dynamic surrogate for histamine microvasculature response. We characterized histamine pharmacodynamics in children using HILD. HILD was performed in 54 children with allergic rhinitis. A non-compartmental analysis and non-linear mixed-effects model with a linked effect PK/PD model was used to provide estimates for area under the effect curve (AUEC), maximal response over baseline (EffmaxNT), and time of EffmaxNT (Tmax). Data were placed in sub-groups by visualization of time vs. response relationships. ANOVA and regression analyses were used for sub-group comparisons. Three histamine response phenotypes were identified. One group demonstrated a hyper-responsive phenotype (higher Tmax, EffmaxNt and AUEC, P < .01). AUEC and EffmaxNT were more strongly associated in this group (r(2)  = 0.86) than the entire cohort (r(2)  = 0.64). These data demonstrate a hyper-responsive histamine phenotype via HILD. This finding is important to future pharmacologic studies of antihistamines.

Citing Articles

The impact of skin color and tone on histamine iontophoresis and Doppler flowmetry measurements as a pharmacodynamic biomarker.

Ramprasad A, Ezekwe A, Lee B, Balasubramanian S, Jones B Clin Transl Sci. 2024; 17(3):e13777.

PMID: 38511581 PMC: 10955605. DOI: 10.1111/cts.13777.


Challenges of pediatric pharmacotherapy: A narrative review of pharmacokinetics, pharmacodynamics, and pharmacogenetics.

Watanabe H, Nagano N, Tsuji Y, Noto N, Ayusawa M, Morioka I Eur J Clin Pharmacol. 2023; 80(2):203-221.

PMID: 38078929 DOI: 10.1007/s00228-023-03598-x.


The Reliability of Histamine Pharmacodynamic Response Phenotype Classification in Children With Allergic Disease.

Kumar S, Liu X, Sherwin C, Jones B Front Pharmacol. 2020; 11:227.

PMID: 32218731 PMC: 7078102. DOI: 10.3389/fphar.2020.00227.


Genetic Variation in the Histamine Production, Response, and Degradation Pathway Is Associated with Histamine Pharmacodynamic Response in Children with Asthma.

Jones B, Sherwin C, Liu X, Dai H, Vyhlidal C Front Pharmacol. 2017; 7:524.

PMID: 28101058 PMC: 5209333. DOI: 10.3389/fphar.2016.00524.


Population pharmacokinetic/pharmacodynamic modeling of histamine response measured by histamine iontophoresis laser Doppler.

Liu X, Jones B, Roberts J, Sherwin C J Pharmacokinet Pharmacodyn. 2016; 43(4):385-93.

PMID: 27307292 PMC: 4994972. DOI: 10.1007/s10928-016-9478-9.


References
1.
Preuss C, Wood T, Szumlanski C, Raftogianis R, Otterness D, Girard B . Human histamine N-methyltransferase pharmacogenetics: common genetic polymorphisms that alter activity. Mol Pharmacol. 1998; 53(4):708-17. DOI: 10.1124/mol.53.4.708. View

2.
Warner J . A double-blinded, randomized, placebo-controlled trial of cetirizine in preventing the onset of asthma in children with atopic dermatitis: 18 months' treatment and 18 months' posttreatment follow-up. J Allergy Clin Immunol. 2001; 108(6):929-37. DOI: 10.1067/mai.2001.120015. View

3.
De Benedictis F, de Benedictis D, Canonica G . New oral H1 antihistamines in children: facts and unmeet needs. Allergy. 2008; 63(10):1395-404. DOI: 10.1111/j.1398-9995.2008.01771.x. View

4.
Grant J, Nicodemus C, Findlay S, Glovsky M, Grossman J, Kaiser H . Cetirizine in patients with seasonal rhinitis and concomitant asthma: prospective, randomized, placebo-controlled trial. J Allergy Clin Immunol. 1995; 95(5 Pt 1):923-32. DOI: 10.1016/s0091-6749(95)70090-0. View

5.
Marone G, Granata F, Spadaro G, Genovese A, Triggiani M . The histamine-cytokine network in allergic inflammation. J Allergy Clin Immunol. 2003; 112(4 Suppl):S83-8. DOI: 10.1016/s0091-6749(03)01881-5. View